Close

Press Releases

Patent plethora in 2010 breaks record for Biocitech technology park residents

Biocitech SAS, the Paris life science technology park, today announced that its 25 resident companies applied for a bumper number of patents with a nearly 70 per cent leap to 147 in 2010. This represents an almost five-fold increase...

Apricus Biosciences Announced European Patient Coverage For Mycova For Nail Fungus

Apricus Biosciences, Inc. announced that the European Patent Office will grant a patent for the company's MycoVaâ„¢ product for treating onychomycosis (commonly referred to as nail fungus). The European Patent Office recently issued a "notice of allowance" for the...

Trophos successfully completes phase 1 study for novel cardioprotective compound, TRO40303

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the successful completion of its phase 1 dose escalation study of TRO40303, a...

Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Rasilamlo(TM) (aliskiren and amlodipine) to treat high blood pressure patients not adequately controlled by either aliskiren or amlodipine alone. Rasilamlo combines in...

CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology testing

CIT – Safety and Health Research Laboratories and Stemina Biomarker Discovery, Inc. announced that CIT and Stemina have entered into a strategic partnership. Under the arrangement, CIT will distribute Stemina’s devTOX(TM) assay in Europe and will work with Stemina...

PharmaDiagnostics awarded European patent for label-free SoPRano ADME assays

PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized instrumentation, announces today that it has been awarded a European patent for its innovative SoPRano ADME assays (absorption, distribution, metabolism, and...

Personalized medicine: The partnership imperative

Cecilia Schott, business development director for personalized healthcare with AstraZeneca, on why partnerships between pharmaceutical and diagnostics companies are key to the success of personalized medicine. AstraZeneca realizes it cannot achieve its mission "to make the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read